Glymphatic system: a pathway for managing endogenous metabolites in CNS

Glymphatic system: a pathway for managing endogenous metabolites in CNS

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2017.

Бібліографічні деталі
Автор:	Tasneem, Sadia
Інші автори:	Archie, Sabrina Rahman
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2021
Предмети:	Glymphatic pathway Alzheimer’s disease CNS Molecular diagnosis Alzheimer's disease > Diagnosis
Онлайн доступ:	http://hdl.handle.net/10361/14373

Схожі ресурси

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
за авторством: Chowdhury, Sariya Uzrat
Опубліковано: (2022)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
за авторством: Aziz, Farhin
Опубліковано: (2019)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
за авторством: Saha, Bithi Rani
Опубліковано: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
за авторством: Alim, Abdul
Опубліковано: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
за авторством: Afra, Sumaiya
Опубліковано: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
за авторством: Tabassum, Nadira
Опубліковано: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
за авторством: Karmaker, Swastika
Опубліковано: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
за авторством: Shehab, Habibul Mohsin
Опубліковано: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
за авторством: Ishrat, Nowshin
Опубліковано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
за авторством: Islam, Md. Irfath
Опубліковано: (2023)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
за авторством: Mahee, Sadique Abdal
Опубліковано: (2024)

Role of circular RNA in neurological disease
за авторством: Salsabil, Labiba
Опубліковано: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
за авторством: Tamanna, Mst. Taskia
Опубліковано: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
за авторством: Hassan, Md. Muhtaz
Опубліковано: (2020)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
за авторством: Bakar, Osama Bin Abu
Опубліковано: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
за авторством: Jahan, Nusrat
Опубліковано: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
за авторством: Tasin, Md Abtahi
Опубліковано: (2023)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
за авторством: Mostofa, Golam
Опубліковано: (2022)

Alzheimer's disease and marriage : an intimate account /
за авторством: Wright, Lore K.
Опубліковано: (1993)

Potential treatments for epigenetic dysregulation in neurological diseases
за авторством: Zaman, Rubaiyat
Опубліковано: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
за авторством: Dey, Manashi
Опубліковано: (2024)

A literature review on the efficacy of test kits for COVID-19
за авторством: Sajid, Saiara Sajita
Опубліковано: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
за авторством: Aana, Afsara Sumon
Опубліковано: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
за авторством: Halim, Rabea
Опубліковано: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
за авторством: Ferdous, Labiba
Опубліковано: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
за авторством: Rahman, Quazi Ashikur, та інші
Опубліковано: (2022)

Marine compounds in the treatment of Alzheimer’s disease
за авторством: Parveen, Sanjana
Опубліковано: (2022)

Skeleton /
за авторством: Parkin, Peter

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
за авторством: Haque, Mushfiqul
Опубліковано: (2019)

An ambient assisted living system for Alzheimer’s patients
за авторством: Abedin, Minhajul, та інші
Опубліковано: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
за авторством: Rithin, Rafia Islam
Опубліковано: (2022)

A review on adult neurogenesis in Alzheimer’s disease
за авторством: Akter, Moriam
Опубліковано: (2022)

Gene editing for neurodegenerative diseases-A review
за авторством: Sharna, Anika Islam
Опубліковано: (2023)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
за авторством: Roy, Aditya, та інші
Опубліковано: (2023)

Early detection of lung cancer risk using data mining
за авторством: Ahmed, Kawsar, та інші
Опубліковано: (2016)

Deep learning based early Glaucoma detection
за авторством: Islam, Aabrar, та інші
Опубліковано: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
за авторством: Sani, Mehedi Hasan, та інші
Опубліковано: (2022)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
за авторством: Mahbub, Riasat, та інші
Опубліковано: (2022)

The role of Artificial Intelligence (AI) in the detection and diagnosis of chronic diseases – a review
за авторством: Zaman, Mumtahina
Опубліковано: (2022)

In vivo evaluation of CNS depressant and antinociceptive activities of different extracts of trewia polycarpa leaves
за авторством: Akter, Nahid
Опубліковано: (2015)